The Potential Game-Changer: Pfizer and BioNTech’s mRNA Vaccine Shows Promising Results

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 Overview Pfizer Inc. and BioNTech SE have announced positive topline results from a Phase 1/2 study evaluating the safety, tolerability, and immune responses of their mRNA-based combination vaccine candidates for influenza and COVID-19. The study demonstrated robust immune responses […]

Unlocking the Potential: The Pioneers Behind Penn’s Historic mRNA Vaccine

Penn Friends and Family Day Celebrates 29th Year A Day of Football, Food, and Fun for Penn Faculty, Staff, and Postdocs The much-anticipated Penn Friends and Family Day is set to return for its 29th year, bringing together faculty, staff, and postdocs for a day of celebration. This year’s event promises an exciting lineup of […]